Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BYAH
BYAH logo

BYAH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Park Ha Biological Technology Co Ltd (BYAH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.320
1 Day change
10.00%
52 Week Range
20.500
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Park Ha Biological Technology Co Ltd (BYAH) is not a strong buy for a beginner, long-term investor at this time. The lack of significant trading trends, neutral technical indicators, and absence of proprietary trading signals suggest limited immediate upside. Additionally, the stock's recent direct offering and partnerships, while positive for long-term growth, may not translate into immediate price appreciation. Given the investor's profile, it is better to wait for clearer signals or stronger fundamentals before investing.

Technical Analysis

The MACD is negatively expanding, indicating bearish momentum. RSI is neutral at 48.204, and moving averages are converging, showing no clear trend. The stock is trading well below key resistance levels, with a pivot at 2.989 and current price at 1.3784.

Positive Catalysts

  • The company has secured $2 million in a direct offering to expand its skincare brand. Additionally, the strategic partnership with Star Plus Action to develop an AI-driven skincare and wellness ecosystem could drive long-term growth.

Neutral/Negative Catalysts

  • The direct offering may dilute existing shareholder value. Technical indicators and stock trend analysis suggest potential short-term price declines, with a 70% chance of -4.25% in the next month.

Financial Performance

No financial data is available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for BYAH.

Wall Street analysts forecast BYAH stock price to rise
Analyst Rating
0
Wall Street analysts forecast BYAH stock price to rise
Buy
Hold
Sell
0
Current: 1.200
sliders
Low
0
Averages
0
High
0
0
Current: 1.200
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch